Early detection of cognitive decline
Cognitive Screening
Position face within frame
Scroll to explore
/ Why early detection matters
The Problem
Delayed detection
75 percent of dementia cases are identified too late for meaningful intervention.
Slow diagnostic pathway
The average diagnostic delay is two years, resulting in limited options for care.
Trial bottlenecks
Clinical trials face recruitment delays that slow the development of new treatments.
/ What we bring to the table
The Solution
Cognes provides a research focused AI solution that captures facial biomarkers through a smartphone and translates subtle signals into interpretable cognitive indicators for long term monitoring.
Capture
A short frontal video is recorded through a standard smartphone camera.
Feature extraction
Geometric and dynamic facial features are identified using computer vision.
AI analysis
Machine learning models estimate cognitive indicators from facial biomarkers.
Interpretation
Outputs support early identification of changes relevant for research.
Long term monitoring
Trends over time help researchers and clinicians detect progression patterns.
/ See it in action
The Screening Flow
Four stages from camera capture to cognitive profile, completed in under sixty seconds on any smartphone.
Position
Cognitive Screening
Position face within frame
The user positions their face within the on-screen guide frame.
Scan
Cognitive Screening
Scanning facial features...
Facial landmarks and biomarker points are detected in real time.
Analyze
Cognitive Screening
Analyzing...
AI processing biomarkers...
AI models process the extracted features against cognitive baselines.
Results
Cognitive Screening
Screening complete
A multi-dimensional cognitive profile is generated for review.
/ Trusted by leading institutions
Building the
future of
AI screening
Dementia and cognitive disorders represent a rapidly expanding global health burden. The demand for accessible, scalable, and non invasive screening tools continues to rise as healthcare systems and research organizations seek faster ways to detect cognitive changes and accelerate treatment development.